GNG4 and bladder transitional cell carcinoma: GNG4 is positively correlated with overall survival under immunotherapy, but, we found that higher expression of GNG4 was associated with worse overall survival (OS) and progression-free survival (PFS) rates in BLCA patients who did not receive immunotherapy (Figure 4A,B).